In addition to serving as clinical trial endpoints, Medical Imaging can be used to monitor cardiac function in clinical trial subjects. Imaging can provide sensitive and quantitative measurements for evaluating cardiac anatomical structure, myocardial perfusion and left ventricular function, a prognostic for congenital heart disease. Bioclinica has the scientific expertise and technological capabilities to offer cardiac safety monitoring through a wide range of imaging modalities.
- Echocardiography (ECHO)
- Computed Tomography Angiography (CTA)
- Cardiac Magnetic Resonance Imaging (MRI)
- Magnetic Resonance Angiography (MRA)
- Positron Emission Tomography (PET)
- Single Photon Emission Computed Tomography (SPECT)
- Multiple Gated Acquisition Scan (MUGA)
With unmatched scientific and medical expertise coupled with industry-leading technology, there is no better partner for your imaging-based clinical trial. We will work closely with you to plan the cardiac safety component of your clinical trial, from protocol development all the way through regulatory submission.
Imaging Facility Qualification
Image quality and associated data, provided within the scope of a clinical trial, can be affected by characteristic flaws of both the imaging system and software. To ensure credible data is acquired during imaging examinations, Bioclinica qualifies partner imaging sites, confirming the sites' adherence to all appropriate regulatory and professional guidelines concerning equipment calibration, testing, and maintenance.
Bioclinica provides oversight in all key areas to optimize image quality including:
- Specification of imaging requirements
- Review of facility imaging capabilities
- Hardware/software assessment
- Quantitative Phantom imaging
- Review of facility quality control program
- Protocol training and technical support
Want to learn more about how Bioclinica's medical imaging services can benefit your cardiac safety study? Contact us today!